Geode Capital Management
SRTA

Geode Capital Management’s Strata Critical Medical Inc SRTA Stock Holding History

Geode Capital Management’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.11M Buy
1,699,710
+45,146
+3% +$217K ﹤0.01% 2562
2025
Q4 		$7.96M Buy
1,654,564
+47,503
+3% +$230K ﹤0.01% 2522
2025
Q3 		$8.13M Buy
1,607,061
+54,128
+3% +$239K ﹤0.01% 2532
2025
Q2 		$6.26M Buy
1,552,933
+131,477
+9% +$428K ﹤0.01% 2615
2025
Q1 		$3.88M Buy
1,421,456
+49,479
+4% +$178K ﹤0.01% 2769
2024
Q4 		$5.83M Sell
1,371,977
-3,318
-0.2% -$12.6K ﹤0.01% 2669
2024
Q3 		$4.04M Buy
1,375,295
+52,274
+4% +$166K ﹤0.01% 2873
2024
Q2 		$4.6M Buy
1,323,021
+36,064
+3% +$120K ﹤0.01% 2778
2024
Q1 		$3.67M Buy
1,286,957
+12,615
+1% +$38.9K ﹤0.01% 2863
2023
Q4 		$4.5M Buy
1,274,342
+89,414
+8% +$257K ﹤0.01% 2761
2023
Q3 		$3.07M Buy
1,184,928
+70,671
+6% +$248K ﹤0.01% 2891
2023
Q2 		$4.39M Buy
1,114,257
+81,713
+8% +$259K ﹤0.01% 2757
2023
Q1 		$3.49M Buy
1,032,544
+42,171
+4% +$172K ﹤0.01% 2794
2022
Q4 		$3.54M Buy
990,373
+29,902
+3% +$128K ﹤0.01% 2837
2022
Q3 		$3.87M Buy
960,471
+9,679
+1% +$49.7K ﹤0.01% 2801
2022
Q2 		$4.24M Buy
950,792
+504,666
+113% +$3.64M ﹤0.01% 2794
2022
Q1 		$3.79M Buy
446,126
+2,488
+0.6% +$17.5K ﹤0.01% 2950
2021
Q4 		$3.92M Sell
443,638
-20,278
-4% -$193K ﹤0.01% 3024
2021
Q3 		$4.82M Sell
463,916
-3,289
-0.7% -$28.7K ﹤0.01% 2932
2021
Q2 		$4.91M Buy
467,205
+452,099
+2,993% +$4.46M ﹤0.01% 2924
2021
Q1 		$155K Buy
+15,106
New +$210K ﹤0.01% 4194

Other funds holding SRTA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
PLC
Pillsbury Lake Capital San Francisco, California $221M AUM
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Geode Capital Management's SRTA Position: Q1 2026 in Review

Geode Capital Management increased its Strata Critical Medical Inc (SRTA) stake by 2.7% in Q1 2026, buying an estimated $217K and bringing the position to 1,699,710 shares worth $7.11M. The position accounts for ﹤0.01% of the portfolio, ranked #2562.

Geode Capital Management first reported a position in SRTA in Q1 2021 and has held it in 21 quarters since. The position peaked at $8.13M in Q3 2025. 125 funds tracked by Wall St. Rank hold SRTA as of Q1 2026.

  • Geode Capital Management held 1,699,710 shares of Strata Critical Medical Inc worth $7.11M as of Q1 2026.
  • Geode Capital Management bought 45,146 Strata Critical Medical Inc shares in Q1 2026, an estimated $217K.
  • Strata Critical Medical Inc made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #2562 holding.
  • Geode Capital Management first reported a position in Strata Critical Medical Inc in Q1 2021 and has held it in 21 quarters since.
  • Geode Capital Management's Strata Critical Medical Inc position peaked at $8.13M in Q3 2025.
  • 125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.